Gram-negative bacterial isolates (63 5) obtained from routine submissions to the Oklahoma Animal Disease Diagnostic Laboratory during 1983-1987 were tested for antimicrobial susceptibility. Minimal inhibitory concentrations (MICs) were determined for the following antimicrobials using commercially prepared microdilution assay materials: ampicillin, cephalothin, chloramphenicol, erythromycin, gentamicin, kanamycin, oxytetracycline, penicillin G, spectinomycin, sulfachlorpyridazine, sulfadimethoxine, and tylosin. Results for isolates from cattle, dogs, horses, and pigs are presented. In only a few instances were differences in MICs apparent among bacterial isolates from different tissues. Aminocyclitol MICs for equine uterine isolates of Klebsiella pneumoniae differed from MICs for isolates from other tissues, and ampicillin, kanamycin, and spectinomycin MICs for bovine fecal isolates of Escherichia coli differed from MICs for isolates obtained from other tissues. In several instances, bimodal distribution of susceptibilities was apparent for ampicillin, kanamycin, and/or oxytetracycline. There was also a bimodal distribution pattern for erythromycin against Pasteurella haemolytica of bovine origin.
Antibiotic selection is typically based on individual for the prospective use) may favor use of an antimiexperience, historical association of disease with spe-crobial that is not so highly effective; one to which a cific drugs, published culture and antibiogram results smaller population (≥ 50%) is susceptible (MIC 50 ) at indicating patterns of susceptibility, or culture and susceptibility testing prior to or during therapy. More recent knowledge of the relative distribution of the various antimicrobials in the animal body and minimal inhibitory concentration (MIC) information have begun to influence both selection and dosage of drugs. As with the traditional Bauer-Kirby disk diffusion susceptibility testing, 4 MICs from large numbers of isolates may be used to indicate patterns of susceptibility or, in individual cases, to guide therapy. Because MIC information is quantitative rather than qualitative, as is disk diffusion susceptibility testing, it may be used as a guide for dosage determinations as well as antibiotic selection.
Optimally, MIC determination prior to therapy is desirable but often not possible. Alternatively, a drug may be selected and given at a dosage that has been shown to be effective for ≥ 90% of isolates tested (MIC 90 ). In some cases, drug costs or drug availability (approved by the US Food and Drug Administration an attainable tissue concentration. The relative distribution of MIC values within the range of values for a given antimicrobial is also of importance and may not be readily apparent from MIC 50 and MIC 90 values. In many instances, the MIC values will be distributed in a graded fashion from the lowest to the highest concentrations in the range. In such instances, gradual increase in antimicrobial concentration results in an increasing number of bacterial isolates being inhibited. In other situations, there may be a bimodal distribution of isolate susceptibility without a gradual transition; one population being inhibited at a relatively low antimicrobial concentration and the other population being affected at a substantially increased concentration. 9 These susceptibility distributions may be important clinically in deciding whether to change dosage of an antimicrobial or whether to change to a different drug.
Although MIC determination is emerging as an important tool in veterinary medicine, its full application has been hindered by lack of available MIC information for animal isolates, which is partly due to technical difficulties and the laborious procedures used in determining MICs by broth dilution methods in tubes. These difficulties have been overcome, to a large extent, by use of commercially available microdilution trays containing various antibiotics in appropriate concentrations for susceptibility testing and the availabil-541 ity of custom-made trays designed to meet the needs sensitivity patterns are indicated in the text. In those of veterinary medicine. 7, 8, 15 The present study was un-instances where limited numbers of isolates were obdertaken to generate MIC data on veterinary isolates tained (< 10), only the MIC 50 is presented. from the midwestern United States. Because initial
The results for equine isolates are presented in used, an additional intermediate dilution was employed for most of the antimicrobials. The trays and their use have been Commercially prepared microdilution described previously. 7 The inoculum obtained from primary trays a containing the following stabilized, dried antimicroisolation medium and subcultured to 3 ml of brain-heart infusion broth was suspended in Mueller-Hinton broth to produce 10 5 bacteria/ml and used to rehydrate (50 µ1) each test well in the tray. The trays were sealed and incubated at 35 C for 18 hr.
recommended ranges, the batch was retested. The MIC was determined as the first well of the row or lowest concentration of antimicrobial without detectable macroscopic growth of bacteria. For the sulfonamides, the MIC was accepted as the lowest concentration in which an 80% reduction of growth was evident in comparison to growth in the control wells.
For quality control purposes, 3 standard strains, Escherichia coli ATCC 25922, Pseudomonas aeruginosa ATCC 27853, and Staphylococcus aureus ATCC 29213, b were used monthly during the study to test the trays for antibiotic activity. In addition, each time a batch of isolates was tested (weekly), at least 1 standard strain was included to check for procedural problems. Expected MIC guidelines, as supplied by the microdilution tray manufacturer, c were followed for the control strains, and when the results were not within the The MICs for bovine isolates are presented in Table  2 . Except for the MIC,, for ampicillin, kanamycin, and possibly spectinomycin, there appears to be little difference between the susceptibilities of E. coli isolates from feces/intestine and those from other tissues. There were no differences in susceptibility between Salmonella isolates from feces and those from other tissues.
Results
For comparison of MIC values, a change of ≥ 2 dilutions was considered different because the accepted tibility populations for E. coli isolates from tissues other than feces/intestine and for Salmonella spp.; slightly more or less than 50% of the isolates had MICs in the 2-4 µg/ml range, whereas the remainder were variability of this methodology is 1 dilution range in > 16 µg/ml. There was a similar pattern for feces/ineither direction. The data (Tables 1-5) are expressed testine E. coli isolates with ampicillin, in which 33% as the MIC 50 and MIC 90 (µg/ml) and are presented of isolates had MICs 2-4 µg/ml, but not with kanamainly by the animal species from which the bacteria mycin. A bimodal distribution of susceptibility was were isolated. Although not shown in most of the taaparent with P. haemolytica isolates against cephalobles, apparent differences in susceptibility of isolates thin and erythromycin with MIC groups of 0.5-2 µg/ among various tissues and the presence of bimodal ml and 1-2 µg/ml, respectively, and ≥ 16 µg/ml. Isolates of E. coli from swine (Table 3) appeared to be similar in susceptibility irrespective of tissue of origin. Except for oxytetracycline, Salmonella and E. coli isolates shared similar susceptibility patterns. A bimodal distribution of susceptibility was apparent for ampicillin with E. coli; the populations were sharply divided between 2-4 µg/ml and > 16 µg/ml.
The MICs for canine isolates are presented in Table  4 . For both E. coli and Pseudomonas aeruginosa, the MICs were similar regardless of the tissue source. There were no apparent bimodal distributions.
The MICs for Salmonella typhimurium, including biotype Copenhagen (14 isolates) , are presented specifically without regard to host animal species in Table  5 . The values for these isolates are also included among the Salmonella spp. isolated from each of the animal species.
Discussion
The MIC 50 and MIC 90 indicate the degree of antimicrobial susceptibility and resistance of a bacterial population and may be used to compare the activity of antimicrobials against common bacteria or to compare the effects of changes in concentration (dosage) of an individual drug. There are numerous reports of in vitro antimicrobial susceptibilities of bacterial pathogens of veterinary importance, but most are presented as traditional antibiograms based on Bauer-Kirby diffusion tests. 10 There are few reports of MIC values. Thus, it is difficult to compare the results of the present Table 2 . Minimal inhibitory concentrations* (µg/ml) of antimicrobials against selected gram-negative bacterial pathogens of bovine origin. study with previously reported values. In addition, nine isolates, efficacy of gentamicin and oxytetracycomparisons are complicated by possible geographic cline against Pseudomonas aeruginosa was greater than differences reflecting various management practices and that in previous reports. 1, 16 Because of the mixing and antimicrobial usage patterns. For both equine and camovement of cattle and the extensive use of antimi- Table 3 . Minimal inhibitory concentrations* (µg/ml) of anti- Table 4 . Minimal inhibitory concentrations* (µg/ml) of antimicrobials against gram-negative bacterial pathogens of porcine ormicrobials aganinst selected gram-negative bacterial pathogens of igin.
canine origin.
crobials in some situations, there are considerable, but not necessarily consistent, differences among reports of MICs for Pasteurella haemolytica and P. multocida.
In the present study, the MICs for oxytetracycline and spectinomycin appear to be consistently higher than those previously reported. 9, 13, 18 Differences in antimicrobial susceptibility of bacteria based on the tissue from which they are isolated may be of considerable importance. Not only are there differences in achievable antimicrobial concentration among various tissues but there may be differences in the susceptibility of bacteria isolated from these tissues. Differences in MICs have previously been shown for P. haemolytica among lung and nasal isolates. 18 In the present study, the MICs for aminocyclitols against K. pneumoniae are lower for uterine isolates than for isolates from other equine tissues. Conversely, the MICs for ampicillin, kanamycin, and spectinomycin against E. coli isolated from bovine feces are distinctly higher than MICs for E. coli isolated from other tissues. This difference may be associated with a greater opportunity for transmissible resistance development in the intestinal tract. 12, 17 In formulation of treatment strategies, the presence of distinct bimodal distribution of populations is im- portant. Bimodal populations were observed for ampicillin, kanamycin, and oxytetracycline susceptibility among the various isolates, especially those of equine origin. This finding is consistent with the bimodal populations previously reported for activity of ampicillin and oxytetracycline against Pasteurella spp. 9 The bimodal pattern for activity of erythromycin against P. haemolytica in the present study is in contrast to a relatively homogenous population reported previously. 9 The presence of distinct bimodal populations signals a probable lack of added response to increased antimicrobial dosages, such that a poor response to initial treatment with a nominal dosage would require a change in antimicrobic rather than increased dosage.
The MIC value alone is of limited value without information on serum/tissue concentrations attainable with specific dosages in a given species of ani-ma1. 3,14,1g Thus, within the context of achievable serum/tissue concentrations, general guidelines can be formulated, delineating antimicrobial concentrations at the upper limits of those achievable for a significant time with nominal dosage. In some cases, MIC data may indicate that routine antimicrobial dosages may be inappropriate due to low achievable serum/tissue concentrations. This factor may be important in justifying extra-label drug dosage, especially with food animals. Although this approach seems to be reasonable and straightforward, there have been few extensive studies to confirm the MIC/dosage relationship. In many cases, it may be difficult to extrapolate a specific dosage from the MIC. At best, reasonable evidence from the MIC may indicate that a labeled dosage will not be adequate or that approved drugs are unlikely to provide appropriate serum/tissue concentrations consistent with the MIC. Perhaps one of drubs is quite rudimentary, and undue emphasis should not be placed on precise serum/tissue concentrations of antimicrobials. The relationship between in vitro susceptibility and in vivo efficacy is yet to be determined satisfactorily. In the simplest approach, it is assumed that tissue concentrations must equal or exceed the MIC during a substantial portion of the treatment interval . 2,3 The duration of this substantial portion will vary with individual drugs because bacteria recover more quickly from the effects of some antimicrobials than from the effects of others. 5,6
